ARGX
argenx NV ADR
NASDAQ: ARGX · HEALTHCARE · BIOTECHNOLOGY
$776.02
+0.13% today
Updated 2026-04-29
Market cap
$48.76B
P/E ratio
39.81
P/S ratio
11.51x
EPS (TTM)
$19.60
Dividend yield
—
52W range
$510 – $935
Volume
0.3M
argenx NV ADR (ARGX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.46M | $2.18M | $3.70M | $4.57M | $7.49M | $15.47M | $43.69M | $24.57M | $78.46M | $41.24M | $497.28M | $410.75M | $1.23B | $2.19B | $4.16B |
| Revenue growth (YoY) | — | +49.7% | +69.4% | +23.5% | +64.1% | +106.5% | +182.3% | -43.8% | +219.3% | -47.4% | +1105.7% | -17.4% | +198.6% | +78.6% | +90.1% |
| Cost of revenue | — | — | $1.02M | $15.29M | $22.41M | $45.19M | $223.83M | $250.56M | $196.82M | $370.88M | $580.52M | $29.43M | $117.83M | $227.29M | $452.06M |
| Gross profit | $1.46M | $2.18M | $2.68M | $4.57M | $7.49M | $15.47M | $43.69M | $24.57M | $78.46M | $41.24M | $497.28M | $381.31M | $1.11B | $1.96B | $3.71B |
| Gross margin | 100.0% | 100.0% | 72.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.8% | 90.4% | 89.6% | 89.1% |
| R&D | $6.25M | $14.63M | $12.91M | $15.37M | $22.56M | $33.19M | $62.07M | $95.64M | $220.77M | $370.49M | $580.52M | $663.37M | $859.49M | $983.42M | $1.37B |
| SG&A | $1.89M | $2.20M | $2.20M | $4.21M | $5.38M | $7.37M | $14.93M | $25.64M | $72.15M | $170.55M | $245.55M | $353.97M | $507.39M | $745.20M | $1.36B |
| Operating income | $-4.72M | $-13.29M | $-8.60M | $-13.06M | $-17.06M | $-22.52M | $-27.51M | $-93.63M | $-198.89M | $-477.62M | $-348.75M | $-720.34M | $-425.05M | $-21.65M | $972.46M |
| Operating margin | -323.6% | -608.9% | -232.7% | -286.1% | -227.7% | -145.6% | -63.0% | -381.0% | -253.5% | -1158.1% | -70.1% | -175.4% | -34.7% | -1.0% | 23.4% |
| EBITDA | $-4.20M | $-12.56M | $-8.29M | $-12.38M | $-16.53M | $-22.17M | $-32.45M | $-93.06M | $-173.35M | $-601.03M | $-392.78M | $-622.78M | $-192.28M | $105.17M | $972.46M |
| EBITDA margin | -288.2% | -575.4% | -224.3% | -271.0% | -220.6% | -143.3% | -74.3% | -378.7% | -220.9% | -1457.3% | -79.0% | -151.6% | -15.7% | 4.8% | 23.4% |
| EBIT | $-4.49M | $-12.82M | $-8.46M | $-12.54M | $-16.74M | $-22.52M | $-32.97M | $-93.63M | $-175.78M | $-604.95M | $-398.65M | $-727.12M | $-303.76M | $87.64M | — |
| Interest expense | $1296.00 | $2645.00 | $5523.00 | $3648.00 | $0.00 | $0.00 | $5.65M | $35.04M | $139000.00 | $403657.00 | $1.10M | $2.19M | $904000.00 | $2.22M | $4.09M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.49M | $-12.83M | $-8.47M | $-12.54M | $-16.74M | $-22.48M | $-33.68M | $-76.23M | $-181.21M | $-608.46M | $-407.63M | $-709.59M | $-295.05M | $833.04M | $1.30B |
| Net income growth (YoY) | — | -185.6% | +34.0% | -48.1% | -33.5% | -34.3% | -49.8% | -126.3% | -137.7% | -235.8% | +33.0% | -74.1% | +58.4% | +382.3% | +55.6% |
| Profit margin | -308.0% | -587.5% | -229.0% | -274.6% | -223.4% | -145.3% | -77.1% | -310.2% | -231.0% | -1475.3% | -82.0% | -172.8% | -24.1% | 38.0% | 31.1% |